Proteomics screening of differentially expressed cytokines in tears of patients with Graves' ophthalmopathy.
The current study was aimed to explore the cytokine profile in the tears of patients with Graves' ophthalmopathy (GO). Approximately 10 ul of tears were sampled from both eyes of each subject using filter paper. Then the levels of up to 34 cytokines in the tears of 7 patients with active GO and 7 healthy volunteers were detected using high-throughput microarray technology in line with the introduction. The results of microarray screening showed that 13 proteins including CD40, CD40 Ligand, GITR, IL-12p70, IL-1 beta, IL-2, IL-21, IL-6, MIP-3 alpha and TRANCE were over-expressed (with fold change >1.20) and 3 proteins including GM-CSF, IL-1 sRI, and IL-13 were down-regulated (with fold change < 0.83) in GO patients. In addition, the protein levels of CD40 and CD40 ligand (CD40L) were significantly different between GO patients and healthy controls (P=028 and 0.011, respectively). Further Gene Ontology and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses of differently expressed proteins showed that these proteins were involved in biological functions including biological processes (positive regulation of cytokine production, JAK-STAT cascade and leukocyte proliferation), molecular functions (cytokine and growth factor receptors binding and cytokine activity), and other important pathways (cytokine-cytokine receptor interaction, JAK-STAT signaling pathway, IL-17 signaling pathway, NF-kappa B signaling pathway, Th17 cell differentiation, and intestinal immune network for IgA production), all of which may involve in the pathology of GO. Our microarray analysis indicated that several proteins were differently expressed in GO patients, which provided potential targets for GO prevention.